1. Home
  2. LFVN vs RFL Comparison

LFVN vs RFL Comparison

Compare LFVN & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$6.69

Market Cap

78.0M

Sector

Health Care

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$2.64

Market Cap

92.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFVN
RFL
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
78.0M
92.6M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
LFVN
RFL
Price
$6.69
$2.64
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
851.7K
274.0K
Earning Date
05-06-2026
06-10-2026
Dividend Yield
3.56%
N/A
EPS Growth
226.09
28.28
EPS
0.30
N/A
Revenue
$203,204,000.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$22.17
N/A
Revenue Growth
1.86
43.96
52 Week Low
$3.90
$1.12
52 Week High
$15.00
$2.95

Technical Indicators

Market Signals
Indicator
LFVN
RFL
Relative Strength Index (RSI) 46.50 73.51
Support Level $5.67 $1.22
Resistance Level $11.71 N/A
Average True Range (ATR) 1.22 0.32
MACD -0.31 0.06
Stochastic Oscillator 19.16 81.75

Price Performance

Historical Comparison
LFVN
RFL

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: